TRANSLATING INNOVATION PROGRAMS
Translating Innovation Programs are a collection of related projects based at TRI which involve collaboration across institutes, technologies and disciplines, united by a common theme. Of the many translational projects underway at TRI, three key Translating Innovation Programs have been identified.
They each consist of related research projects that are designed to address a clinical need, and develop new or improved interventions or therapeutics to improve health outcomes for patients.
Find out more about these TRI Translating Innovation Programs below.
.png)
Australian Centre for Complex Integrated Surgical Solutions (ACCISS)
The Australian Centre for Complex Surgical Solutions (ACCISS) uses an innovative planning approach bringing together expertise and clinically applied digital innovations to solve complicated surgical cases. The success of the outcome is then shared, and the new treatment adopted into clinical trials and practice.
ACCISS offers hope that difficult clinical problems can be solved. This innovative approach brings together the diverse range of expertise needed to find a solution which may incorporate engineering, bioinformatics, software design, surgery and manufacturing capability and infrastructure to create a virtual surgical planning sphere, which allows surgeons to perform steps of the procedure before the patient is on the table. With clinically applied digital innovations emerging so quickly, it can be difficult for clinicians to access new technology even when they have a good understanding of how it can help. This is important for complex problems where outcomes are unpredictable.
Read more about the ACCISS Program at TRI
Immunotherapy
It could be said that TRI was built on immunotherapy, with many of the main translational projects in this program making significant progress - including the cervical cancer and rheumatoid arthritis vaccine projects, which are world-class examples of immunotherapy success.
diagnostic Imaging
Introduced TRI with the appointment of then CEO Professor Carolyn Mountford in 2015, this program is a collection of imaging projects using diagnostic imaging techniques to understand the gut/brain axis, pre-cancerous changes to breast tissue in high-risk women, changes to brain chemistry in PTSD, and trauma from blast injury or full contact sports.
> Read more about the Diagnostic Imaging Program at TRI
Microbiome
This Program was established at TRI to address the need to expand our knowledge about the role of the human microbiome in health and disease.
